According to a new report from Intel Market Research, the global Enoxaparin Sodium market was valued at USD 3.30 billion in 2025 and is projected to reach USD 6.71 billion by 2034, growing at a robust CAGR of 8.2% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of venous thromboembolism, the aging population experiencing higher incidences of...